573 related articles for article (PubMed ID: 29703699)
1. Oncolytic Virus Combination Therapy: Killing One Bird with Two Stones.
Martin NT; Bell JC
Mol Ther; 2018 Jun; 26(6):1414-1422. PubMed ID: 29703699
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial Approaches for Cancer Treatment Using Oncolytic Viruses: Projecting the Perspectives through Clinical Trials Outcomes.
Malogolovkin A; Gasanov N; Egorov A; Weener M; Ivanov R; Karabelsky A
Viruses; 2021 Jun; 13(7):. PubMed ID: 34209981
[TBL] [Abstract][Full Text] [Related]
3. Integrating oncolytic viruses in combination cancer immunotherapy.
Bommareddy PK; Shettigar M; Kaufman HL
Nat Rev Immunol; 2018 Aug; 18(8):498-513. PubMed ID: 29743717
[TBL] [Abstract][Full Text] [Related]
4. Harnessing the Power of Onco-Immunotherapy with Checkpoint Inhibitors.
Rajani KR; Vile RG
Viruses; 2015 Nov; 7(11):5889-901. PubMed ID: 26580645
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic Immunotherapy for Treatment of Cancer.
Tsun A; Miao XN; Wang CM; Yu DC
Adv Exp Med Biol; 2016; 909():241-83. PubMed ID: 27240460
[TBL] [Abstract][Full Text] [Related]
6. Viruses for tumor therapy.
Bell J; McFadden G
Cell Host Microbe; 2014 Mar; 15(3):260-5. PubMed ID: 24629333
[TBL] [Abstract][Full Text] [Related]
7. A promising future in cancer immunotherapy: Oncolytic viruses.
Seyed-Khorrami SM; Azadi A; Rastegarvand N; Habibian A; Soleimanjahi H; Łos MJ
Eur J Pharmacol; 2023 Dec; 960():176063. PubMed ID: 37797673
[TBL] [Abstract][Full Text] [Related]
8. Combination of virotherapy and T-cell therapy: arming oncolytic virus with T-cell engagers.
Song XT
Discov Med; 2013 Dec; 16(90):261-6. PubMed ID: 24333405
[TBL] [Abstract][Full Text] [Related]
9. Virus combinations and chemotherapy for the treatment of human cancers.
Kumar S; Gao L; Yeagy B; Reid T
Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
[TBL] [Abstract][Full Text] [Related]
10. Current strategies of virotherapy in clinical trials for cancer treatment.
Lin W; Zhao Y; Zhong L
J Med Virol; 2021 Aug; 93(8):4668-4692. PubMed ID: 33738818
[TBL] [Abstract][Full Text] [Related]
11. Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1.
Thomas S; Kuncheria L; Roulstone V; Kyula JN; Mansfield D; Bommareddy PK; Smith H; Kaufman HL; Harrington KJ; Coffin RS
J Immunother Cancer; 2019 Aug; 7(1):214. PubMed ID: 31399043
[TBL] [Abstract][Full Text] [Related]
12. The role of oncolytic virus immunotherapies to subvert cancer immune evasion.
Workenhe ST; Verschoor ML; Mossman KL
Future Oncol; 2015; 11(4):675-89. PubMed ID: 25686121
[TBL] [Abstract][Full Text] [Related]
13. Oncolytic viruses in cancer therapy.
Vähä-Koskela MJ; Heikkilä JE; Hinkkanen AE
Cancer Lett; 2007 Sep; 254(2):178-216. PubMed ID: 17383089
[TBL] [Abstract][Full Text] [Related]
14. Herpes Simplex Virus Oncolytic Immunovirotherapy: The Blossoming Branch of Multimodal Therapy.
Menotti L; Avitabile E
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167582
[TBL] [Abstract][Full Text] [Related]
15. Oncolytic virotherapy as immunotherapy.
Melcher A; Harrington K; Vile R
Science; 2021 Dec; 374(6573):1325-1326. PubMed ID: 34882456
[TBL] [Abstract][Full Text] [Related]
16. Oncolytic virus immunotherapy: future prospects for oncology.
Raja J; Ludwig JM; Gettinger SN; Schalper KA; Kim HS
J Immunother Cancer; 2018 Dec; 6(1):140. PubMed ID: 30514385
[TBL] [Abstract][Full Text] [Related]
17. Oncolytic viruses: finally delivering.
Seymour LW; Fisher KD
Br J Cancer; 2016 Feb; 114(4):357-61. PubMed ID: 26766734
[TBL] [Abstract][Full Text] [Related]
18. From virotherapy to oncolytic immunotherapy: where are we now?
Coffin RS
Curr Opin Virol; 2015 Aug; 13():93-100. PubMed ID: 26121656
[TBL] [Abstract][Full Text] [Related]
19. Modification of oncolytic adenovirus and its application in cancer therapy.
Liang Y; He J; Zhao Y
Discov Med; 2020; 30(161):129-144. PubMed ID: 33593481
[TBL] [Abstract][Full Text] [Related]
20. Oncolytic viruses in the treatment of cancer: a review of current strategies.
Zeyaullah M; Patro M; Ahmad I; Ibraheem K; Sultan P; Nehal M; Ali A
Pathol Oncol Res; 2012 Oct; 18(4):771-81. PubMed ID: 22714538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
